Hida

Alps Pharmaceutical confirms through human pharmacokinetic studies that its newly developed natural quercetin formulation can significantly reduce quercetin usage

Retrieved on: 
Monday, August 1, 2022
Hida, Absorption, Water, Capsule, Capsaicin, Quercetin, Tablet, Beth Israel Hospital, Health, Nutrient, Flavonoid, Kampo, Vegetable, Plant, SDG, Harvard Medical School, Solubility, Pharmaceutical industry, Dietary supplement

Co., Ltd. (Hida, Japan, President: Osamu Ushimaru) announced that it has confirmed through human pharmacokinetic studies of its new quercetin formulation, EubioQuercetin, that the amount of quercetin used can be reduced to one quarter of the original amount.

Key Points: 
  • Co., Ltd. (Hida, Japan, President: Osamu Ushimaru) announced that it has confirmed through human pharmacokinetic studies of its new quercetin formulation, EubioQuercetin, that the amount of quercetin used can be reduced to one quarter of the original amount.
  • Health occupies a central position in the SDG 3, and quercetin is a supplement that plays a significant role in achieving this global goal.
  • To accomplish this, Alps Pharmaceutical has spent many years researching natural quercetin and has finally succeeded in developing EubioQuercetin, a new quercetin formulation made from only safe and natural food ingredients.
  • "Natural quercetin, found in fruits and vegetables, is fully absorbed by the body and contributes to good health.

Alps Pharmaceutical confirms through human pharmacokinetic studies that its newly developed natural quercetin formulation can significantly reduce quercetin usage

Retrieved on: 
Monday, August 1, 2022
Hida, Absorption, Water, Capsule, Capsaicin, Quercetin, Tablet, Beth Israel Hospital, Health, Nutrient, Flavonoid, Kampo, Vegetable, Plant, SDG, Harvard Medical School, Solubility, Pharmaceutical industry, Dietary supplement

Co., Ltd. (Hida, Japan, President: Osamu Ushimaru) announced that it has confirmed through human pharmacokinetic studies of its new quercetin formulation, EubioQuercetin, that the amount of quercetin used can be reduced to one quarter of the original amount.

Key Points: 
  • Co., Ltd. (Hida, Japan, President: Osamu Ushimaru) announced that it has confirmed through human pharmacokinetic studies of its new quercetin formulation, EubioQuercetin, that the amount of quercetin used can be reduced to one quarter of the original amount.
  • Health occupies a central position in the SDG 3, and quercetin is a supplement that plays a significant role in achieving this global goal.
  • To accomplish this, Alps Pharmaceutical has spent many years researching natural quercetin and has finally succeeded in developing EubioQuercetin, a new quercetin formulation made from only safe and natural food ingredients.
  • "Natural quercetin, found in fruits and vegetables, is fully absorbed by the body and contributes to good health.

ALPS PHARMA LAUNCHES A NEW WATER-SOLUBLE ISOQUERCETIN COMPOSITION WITH HIGHER ABSORPTION RATE

Retrieved on: 
Saturday, February 26, 2022
Health, Kampo, Hida, Water, Thrombosis, Database, Medicine, Food, Capsaicin, Phytochemical, Rutin, Beth Israel Deaconess Medical Center, QOL, Patient, Solubility, PDI, Harvard University, Absorption, ALPS, Pharmaceutical industry, Quercetin, Isoquercetin

 https://health-alps--pharm-co-jp.translate.goog/report/?_x_tr_sl=ja&_x_t...

Key Points: 
  • Co., Ltd. (President: Osamu Ushimaru), a global pharmaceutical company that pioneered the use of phytochemicals in medicine and food, announced the launch of a new Isoquercetin composition, EubioIsoquercetin, today.
  • EubioIsoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin.
  • EubioIsoquercetin, a water-soluble Isoquercetin composition, protected by three related U.S. patents, demonstrated a significantly higher Quercetin absorbability rate than ordinary Isoquercetin in a human pharmacokinetics study.
  • EubioIsoquercetin is only formulated with all natural food ingredients and is the first formula to achieve a higher absorption of Quercetin into the body without enzymatic modification.

ALPS PHARMA LAUNCHES A NEW WATER-SOLUBLE ISOQUERCETIN COMPOSITION WITH HIGHER ABSORPTION RATE

Retrieved on: 
Saturday, February 26, 2022
Health, Kampo, Hida, Water, Thrombosis, Database, Medicine, Food, Capsaicin, Phytochemical, Rutin, Beth Israel Deaconess Medical Center, QOL, Patient, Solubility, PDI, Harvard University, Absorption, ALPS, Pharmaceutical industry, Quercetin, Isoquercetin

 https://health-alps--pharm-co-jp.translate.goog/report/?_x_tr_sl=ja&_x_t...

Key Points: 
  • Co., Ltd. (President: Osamu Ushimaru), a global pharmaceutical company that pioneered the use of phytochemicals in medicine and food, announced the launch of a new Isoquercetin composition, EubioIsoquercetin, today.
  • EubioIsoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin.
  • EubioIsoquercetin, a water-soluble Isoquercetin composition, protected by three related U.S. patents, demonstrated a significantly higher Quercetin absorbability rate than ordinary Isoquercetin in a human pharmacokinetics study.
  • EubioIsoquercetin is only formulated with all natural food ingredients and is the first formula to achieve a higher absorption of Quercetin into the body without enzymatic modification.

Decision Resources Group Announced as HIDA Industry Data Program Partner

Retrieved on: 
Thursday, February 13, 2020
Hida

BURLINGTON, Mass., Feb. 13, 2020 /PRNewswire/ --Decision Resources Group (DRG), www.decisionresourcesgroup.com , a premier provider of high-value healthcare data, analytics, and insights products and services to the healthcare industry, has been named as the new partner for the Health Industry Distributors Association (HIDA) industry data program.

Key Points: 
  • BURLINGTON, Mass., Feb. 13, 2020 /PRNewswire/ --Decision Resources Group (DRG), www.decisionresourcesgroup.com , a premier provider of high-value healthcare data, analytics, and insights products and services to the healthcare industry, has been named as the new partner for the Health Industry Distributors Association (HIDA) industry data program.
  • Beginning January 1, 2021, DRG will exclusively manage HIDA's data program, including data aggregation, related services and commercial operations.
  • "We are excited to be selected to partner with HIDA on producing this industry-leading data solution," said Ken McLaren, DRG Chief Strategy and Execution Officer.
  • We are looking forward to enhancing the HIDA program through our AI and machine learning capabilities, and through DRG's continued commitment to customer-centricity."

Japan House Announces New Exhibition “HIDA | A Woodwork Tradition in the Making”

Retrieved on: 
Thursday, January 2, 2020
Chūbu region, Hida

LOS ANGELES, Jan. 02, 2020 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles is proud to announce the exhibition HIDA | A Woodwork Tradition in the Making, which brings Japanese woodcraft from its spiritual homeland of the Hida region of Japan to Los Angeles for the first time.

Key Points: 
  • LOS ANGELES, Jan. 02, 2020 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles is proud to announce the exhibition HIDA | A Woodwork Tradition in the Making, which brings Japanese woodcraft from its spiritual homeland of the Hida region of Japan to Los Angeles for the first time.
  • The exhibition will also spotlight where tradition meets technology and innovation, such as Hida Sangyos revolutionary wood compression techniques with cedar.
  • For audiences passionate about craft heritage, sustainable business, or a closer connection with our natural world, HIDA | A Woodwork Tradition in the Making is not to be missed.
  • JAPAN HOUSE Los Angeles offers a place of new discovery that transcends the physical and conceptual boundaries creating experiences that reflect the best of Japan through its spaces and diverse programs.